http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022050105-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc48cf341eaa3befbb18f2f9de9a3b6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0681 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-5027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00 |
| filingDate | 2020-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c3147bc1744aae28c126af5b39ecabf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cd0d98680e16f9ac4e93a53dca5ca4 |
| publicationDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022050105-A1 |
| titleOfInvention | Method and apparatus for detecting viruses in biological samples |
| abstract | The present invention relates to a process for detecting a virus that include the steps of: taking a biosample (e.g. saliva) suspected of containing a virus, mixing it with a solution comprising nanoparticles having easily detectable properties (e.g. a color) and also comprising contrasting microparticles (e.g. clear or white), each having attached chemical compounds (e.g. antibodies) that selectively bind to the virus to be detected (e.g. SARS-CoV-2). When suitably mixed together, virus present in the biosample may bind to the nanoparticles and to the microparticles, connecting the two. When the mixture is then passed through a microfluidic assembly with dimensions that trap the microparticles but pass unbound nanoparticles, the detection of the presence of nanoparticles bound to the microparticles at the microfluidic filter indicates the presence of the virus to be detected. The process may include a concentration step to accelerate binding the virus to the nano- and micro-particles. |
| priorityDate | 2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.